CNBC-TV18's Archana Shukla reports that India's grant of a compulsory licence to Natco for Bayer's kidney-cancer drug Nexavar has sent shockwaves across the globe
first published: Aug 17, 2012 09:54 pm
A collection of the most-viewed Moneycontrol videos.

Live: Will Nifty continue to chase 26,000? | Opening Bell

Stock Market LIVE: Sensex, Nifty Off Day’s Lows | F&O Expiry Sparks Volatility | Closing Bell

‘Ashoka University Won’t Expand to Other Cities’ | Pramath Raj Sinha & Ashish Dhawan LIVE

Live: Nifty to test 26,000-mark on monthly expiry day | Opening Bell
You are already a Moneycontrol Pro user.

